Provided by Tiger Trade Technology Pte. Ltd.

First Trust Nasdaq Pharmaceuticals ETF

41.27
+0.82002.03%
Post-market: 41.270.00000.00%18:39 EDT
Volume:1.26M
Turnover:52.12M
Market Cap:1.06B
PE:- -
High:41.37
Open:40.60
Low:40.60
Close:40.45
52wk High:43.52
52wk Low:28.77
Shares:25.80M
Float Shares:25.80M
Volume Ratio:15.04
T/O Rate:4.90%
Dividend:0.29
Dividend Rate:0.71%
ROE:--
ROA:--
PB:--
PE(LYR):- -

Loading ...

S&P 500 Top and Bottom Performing Stocks at About 12:00 P.m. EDT

Reuters
·
Oct 09

Dow's Nearly 150-Point Fall Led by Losses for Shares of Amgen, Johnson & Johnson

Dow Jones
·
Oct 08

AbbVie (ABBV) Lands Two FDA Breakthrough Tags For Temab A In Cancer

Simply Wall St.
·
Oct 08

1s Could Offer Unexpected Relief from Back and Knee Pain, but Doctors Urge Caution

Dow Jones
·
Oct 08

Bristol-Myers Squibb (BMY) Receives a Buy from J.P. Morgan

TIPRANKS
·
Oct 08

Merck & Company (MRK) Receives a Buy from BMO Capital

TIPRANKS
·
Oct 08

How to invest in healthcare stocks without picking the next Eli Lilly

Simply Wall St.
·
Oct 08

Bristol Myers’ zenbexus in combination shows efficacy in Phase 3 myeloma trial

TIPRANKS
·
Oct 08

Bristol Myers Squibb Says Zenbexus Combo Cuts Multiple Myeloma Progression Risk 51% in Phase 3 Excaliber-RRMM Trial

Reuters
·
Oct 08

Bristol Myers Squibb Announces Zenbexustm (Iberdomide) in Combination with Daratumumab and Dexamethasone (Zdd) Demonstrates Superior Progression-Free Survival VS. Standard of Care in Relapsed and Refractory Multiple Myeloma in Phase 3...

THOMSON REUTERS
·
Oct 08

Bristol-Myers Squibb Company - Excaliber Study Shows Pfs Hazard Ratio of 0.49 vs Standard of Care

THOMSON REUTERS
·
Oct 08

Bristol-Myers Squibb Company - Zenbexus Safety Profile Consistent with Previously Reported Findings

THOMSON REUTERS
·
Oct 08

Bristol-Myers Squibb Company - Zdd Median Pfs 42 Months vs 20 Months for Dvd; 51% Risk Reduction

THOMSON REUTERS
·
Oct 08

Bristol-Myers Squibb Company - Serious Adverse Reactions in 58.3% and Fatal in 4.9% of Zenbexus Patients

THOMSON REUTERS
·
Oct 08

Analysts Conflicted on These Healthcare Names: Johnson & Johnson (JNJ) and NeoGenomics (NEO)

TIPRANKS
·
Oct 08

Dow Falls Over 300 Points As Treasury Yields Surge: Investor Sentiment Weakens, Fear & Greed Index Remains In ‘Neutral’ Zone

Benzinga Earnings
·
Oct 08

Health Care up on Defensive Bias

Dow Jones
·
Oct 08

3 ‘Strong Buy’ Dividend Aristocrat Stocks on Analysts’ Watch List

TIPRANKS
·
Oct 08

Estee Lauder Cos. Cl a Stock Underperforms Wednesday When Compared to Competitors Despite Daily Gains

Dow Jones
·
Oct 08

Eli Lilly & Co. Stock Outperforms Competitors on Strong Trading Day

Dow Jones
·
Oct 08